1. Home
  2. PHIO vs POLA Comparison

PHIO vs POLA Comparison

Compare PHIO & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • POLA
  • Stock Information
  • Founded
  • PHIO 2011
  • POLA 1979
  • Country
  • PHIO United States
  • POLA United States
  • Employees
  • PHIO N/A
  • POLA N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • PHIO Health Care
  • POLA Miscellaneous
  • Exchange
  • PHIO Nasdaq
  • POLA Nasdaq
  • Market Cap
  • PHIO 12.1M
  • POLA 11.5M
  • IPO Year
  • PHIO N/A
  • POLA 2016
  • Fundamental
  • Price
  • PHIO $2.16
  • POLA $4.06
  • Analyst Decision
  • PHIO Strong Buy
  • POLA
  • Analyst Count
  • PHIO 3
  • POLA 0
  • Target Price
  • PHIO $10.67
  • POLA N/A
  • AVG Volume (30 Days)
  • PHIO 70.7K
  • POLA 844.5K
  • Earning Date
  • PHIO 11-13-2025
  • POLA 11-13-2025
  • Dividend Yield
  • PHIO N/A
  • POLA N/A
  • EPS Growth
  • PHIO N/A
  • POLA N/A
  • EPS
  • PHIO N/A
  • POLA N/A
  • Revenue
  • PHIO N/A
  • POLA $11,967,000.00
  • Revenue This Year
  • PHIO N/A
  • POLA N/A
  • Revenue Next Year
  • PHIO N/A
  • POLA N/A
  • P/E Ratio
  • PHIO N/A
  • POLA N/A
  • Revenue Growth
  • PHIO N/A
  • POLA 0.14
  • 52 Week Low
  • PHIO $0.97
  • POLA $1.53
  • 52 Week High
  • PHIO $9.79
  • POLA $5.75
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 47.27
  • POLA 53.66
  • Support Level
  • PHIO $2.08
  • POLA $3.38
  • Resistance Level
  • PHIO $2.17
  • POLA $3.99
  • Average True Range (ATR)
  • PHIO 0.10
  • POLA 0.50
  • MACD
  • PHIO -0.01
  • POLA -0.14
  • Stochastic Oscillator
  • PHIO 25.64
  • POLA 30.21

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: